CFA
ALXN

Camarda Financial Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Camarda Financial Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37
Closed -$5K – 502
2019
Q2 		$5K Buy
+37
New +$4.77K 0.01% 210
2017
Q1 		– Sell
-19
Closed -$2K – 265
2016
Q4 		$2K Buy
+19
New +$2.33K ﹤0.01% 231
2016
Q1 		– Sell
-1,184
Closed -$226K – 316
2015
Q4 		$226K Buy
+1,184
New +$207K 0.14% 90
2015
Q2 		– Sell
-232
Closed -$40K – 282
2015
Q1 		$40K Buy
232
+71
+44% +$12.9K 0.02% 147
2014
Q4 		$30K Buy
+161
New +$29.8K 0.02% 165

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return